Hubei Fuxing Science and TechnologyLtd Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

-51.4%

Wachstumsrate der Gewinne

-51.3%

EPS-Wachstumsrate

Real Estate Wachstum der Industrie	-5.2%
Wachstumsrate der Einnahmen	-3.1%
Eigenkapitalrendite	0.6%
Netto-Marge	0.1%
Letzte Ertragsaktualisierung	30 Sep 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Aufschlüsselung der Einnahmen und Ausgaben

Wie Hubei Fuxing Science and TechnologyLtd Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

XSEC:000926 Einnahmen, Ausgaben und Erträge (CNY Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten	F&E-Ausgaben
30 Sep 24	3,352	4	275	35
30 Jun 24	3,776	32	320	37
31 Mar 24	5,213	81	400	36
31 Dec 23	5,508	68	444	35
30 Sep 23	10,390	125	731	33
30 Jun 23	10,412	106	783	31
31 Mar 23	14,867	110	857	33
01 Jan 23	15,142	105	833	35
30 Sep 22	13,324	115	651	37
30 Jun 22	17,484	124	805	43
31 Mar 22	12,329	138	720	47
01 Jan 22	12,544	171	758	52
30 Sep 21	11,822	213	735	55
30 Jun 21	7,529	201	600	52
31 Mar 21	8,060	266	659	50
31 Dec 20	7,501	306	602	38
30 Sep 20	7,938	400	631	36
30 Jun 20	7,572	410	680	40
31 Mar 20	7,444	490	755	51
31 Dec 19	9,566	598	712	48
30 Sep 19	9,298	870	750	40
30 Jun 19	10,348	964	669	29
31 Mar 19	11,465	1,121	562	9
31 Dec 18	10,735	1,135	660	9
30 Sep 18	11,754	696	595	9
30 Jun 18	11,720	968	557	14
31 Mar 18	11,333	793	543	9
31 Dec 17	11,659	845	520	9
30 Sep 17	9,096	733	567	6
30 Jun 17	10,169	703	594	0
31 Mar 17	10,388	600	592	0
31 Dec 16	10,485	581	626	0
30 Sep 16	10,271	628	570	0
30 Jun 16	10,085	560	614	0
31 Mar 16	8,951	533	581	0
31 Dec 15	8,029	469	557	0
30 Sep 15	8,681	688	515	0
30 Jun 15	7,508	784	509	0
31 Mar 15	8,164	787	540	0
31 Dec 14	7,879	734	512	0
30 Sep 14	8,169	735	487	0
30 Jun 14	8,631	593	424	0
31 Mar 14	8,149	683	394	0
31 Dec 13	7,663	672	362	0

Hubei Fuxing Science and TechnologyLtd Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.005 profit in 3Q 2023)

Hubei Fuxing Science and Technology Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.025 profit in 2Q 2023)

Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2024 Results on Aug 31, 2024

Hubei Fuxing Science and Technology Co.,Ltd to Report Q1, 2024 Results on Apr 29, 2024

Third quarter 2023 earnings released: CN¥0.036 loss per share (vs CN¥0.014 loss in 3Q 2022)

Recent updates

New minor risk - Profit margin trend

Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.005 profit in 3Q 2023)

Hubei Fuxing Science and Technology Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

New minor risk - Share price stability

New major risk - Financial position

Second quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.025 profit in 2Q 2023)

Hubei Fuxing Science and Technology Co.,Ltd Approves Election of Ke Jiuming as Director

Investor sentiment deteriorates as stock falls 18%

New major risk - Revenue and earnings growth

Hubei Fuxing Science and Technology Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 8 July 2024

Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2024 Results on Aug 31, 2024

New major risk - Financial position

Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, May 31, 2024

Investor sentiment improves as stock rises 16%

Hubei Fuxing Science and Technology Co.,Ltd to Report Q1, 2024 Results on Apr 29, 2024

Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million.

Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million.

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: CN¥0.036 loss per share (vs CN¥0.014 loss in 3Q 2022)

Hubei Fuxing Science and Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 29, 2024

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.014 loss in 3Q 2022)

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CN¥0.035 (vs CN¥0.04 in 2Q 2022)

Investor sentiment improves as stock rises 18%

Hubei Fuxing Science and Technology Co.,Ltd Announces Final Dividend on A Shares for the Year 2022, Payable on July 31, 2023

Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, Jun 02, 2023

First quarter 2023 earnings released: EPS: CN¥0.044 (vs CN¥0.04 in 1Q 2022)

Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 1.3 billion in funding

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: CN¥0.014 loss per share (vs CN¥0.005 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.059 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hubei Fuxing Science and Technology Co.,Ltd Announces No Dividend for 2021

Full year 2021 earnings released: EPS: CN¥0.18 (vs CN¥0.32 in FY 2020)

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: CN¥0.005 loss per share (vs CN¥0.02 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.059 (vs CN¥0.13 in 2Q 2020)

Hubei Fuxing Science and Technology Co.,Ltd Approves Cash Dividend

First quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.11 in 1Q 2020)

Hubei Fuxing Science and Technology Co.,Ltd Proposes Final Dividend for the Year 2020

Hubei Fuxing Science and Technology Co.,Ltd(XSEC:000926) dropped from S&P Global BMI Index

New 90-day low: CN¥4.63

New 90-day low: CN¥4.77

New 90-day low: CN¥5.01

Third quarter earnings released

New 90-day low: CN¥5.23

New 90-day low: CN¥5.27

Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 3 billion in funding

Hubei Fuxing Science and Technology Co.,Ltd announced that it has received CNY 3 billion in funding

First half earnings released

Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren